Treatment of the primary hyperoxalurias: a new chapter.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16988727.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.
Medical subject headings
- Hyperoxaluria, Primary
- Oxalobacter formigenes